Merus
Price & Volume
Stats
See moreOpen | $44.71 |
Previous Close | $44.35 |
Day Range | $44.71-$46.92 |
52W Range | $22.26-$61.61 |
Market Cap | $2.9B |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $35.9M |
Revenue Growth (YoY) | 6.7% |
Gross Profit (12 Mos) | -$107.8M |
Diluted EPS | -$4.03 |
News
See moreYahoo Finance • 4 months ago
Merus Announces First Patient Dosed in LiGeR-HN2, a Phase 3 Trial Evaluating Petosemtamab in 2/3L r/m HNSCC
Yahoo Finance • 12 months ago
Merus kündigt Veröffentlichung von Abstracts zu MCLA-129 für die Präsentation auf dem ESMO Asia Congress 2023 an
Yahoo Finance • 12 months ago
Merus Announces Publication of Abstracts on MCLA-129 for Presentation at ESMO Asia Congress 2023
About
CEO | Dr. Sven Ante Lundberg M.D. |
Address | Uppsalalaan 17, Utrecht, Netherlands, 3584 CT |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 172 |
